Health
Health Ministry seeks separate licences for wholesale sale of bulk drugs
The Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945, creating a dedicated licensing route for bulk drugs. The draft introduces separate application and licence forms for bulk drugs, apart from the current provisions for formulations. Presently, a single licence covers wholesale of both, the ministry said in a statement.
According to the ministry, the licence will cover the categories of bulk drugs handled by wholesalers, including drugs under the Narcotic Drugs and Psychotropic Substances Act, 1985. Sales must take place under the supervision of a competent person. The ministry said this would tighten control over wholesale dealings and support enforcement on antimicrobial resistance and the movement of such drugs. The Drugs Consultative Committee agreed to the proposal at its 67th meeting on November 17, 2025, and the Drugs Technical Advisory Board at its 93rd meeting on February 16, 2026.
Existing licensees will get adequate time to adjust. The new rules will apply to them after their current retention period ends or 12 months after final publication, whichever is later. Stakeholders and the public may send objections and suggestions within 30 days of the date copies of the draft gazette are made available.
Key points
- The Health Ministry has proposed a separate licence framework for wholesale trade in bulk drugs.
- Currently a common licence covers wholesale of both formulations and bulk drugs.
- The licence will cover bulk drugs under the Narcotic Drugs and Psychotropic Substances Act, 1985, the ministry said.
- The ministry said the change would strengthen oversight and accountability in the supply chain.
- Existing licensees get time to comply, and objections can be filed within 30 days of the gazette copies becoming available.
Coverage from
This story was put together automatically from the sources above. Open a source to read its original report. How nuze makes stories